13 Październik 2023
Sofia, Bulgaria, October 13, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that today the Company received a notification for significant shareholding from Ognian Donev. As a result of exercising warrants from issue BG9200001212 and participation in the conditional capital increase, Ognian Donev crosses the threshold of 5% and increases his shareholding in the capital of the Company to 8.445%.